Buy THJ-2201 online
Buy THJ-2201 online:THJ-2201 is an indazole-based engineered cannabinoid that probably goes about as a powerful agonist of the CB1 receptor and has been sold online as an architect drug.It is an auxiliary simple of AM-2201 in which the focal indole ring has been replaced by indazole.
THJ-2201 goes about as a full agonist with a coupling fondness of 1.34nM at CB1 and 1.32nM at CB2 cannabinoid receptors
THJ-2201
Buy from RESEARCH CHEMS ONLINE at affordable rates. We offer the best research chemicals and deliver worldwide.
All products are are discreetly packaged and shipped in discreet mode for our clients’ privacy and security. We accept a variety of secure payment options and discounts for high volume purchases.
THJ-2201 (1-[(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone) is a synthetic cannabinoid and analog of AM-2201. It has been marketed by many research chemical vendors as a legal alternative to the popular AM-2201, which had been banned in 2011.
Cannabinoids are commonly smoked or vaporized to achieve a quick onset of effects and rapid offset. THJ-2201 is orally active when dissolved in a lipid, which can increase the duration significantly. Like other cannabinoids, it is insoluble in water but dissolves in ethanol and lipids.
Unlike cannabis, the chronic abuse of synthetic cannabinoids has been associated with multiple deaths and more dangerous side effects and toxicity in general. Therefore, it is strongly discouraged to take this substance for extended periods of time or in excessive doses.
Synonyms of THJ-2201
AM2201 indazole analog
5-fluoropentyl JWH 018 indazole analog
5-fluoro THJ 018
Technical Information
Formal Name
[1-(5-fluoropentyl)-1H-indazol-3-yl]-1-naphthalenyl-methanone
CAS Number
1801552-01-1
Molecular Formula
C23H21FN2O
Formula Weight
360.4
Purity
≥98%
Formulation
A crystalline solid
Pharmacology
Although this substance has not been formally studied, from analysis of the structure, it is presumed that THJ-2201 has a similar binding profile to that of AM-2201 and matches many of the in vivo properties of Δ9-THC. As with AM-2201, this compound is believed to act as a potent full agonist to the central CB1 and peripheral CB2 receptors with Ki values of 1.0 and 2.6nM respectively. However, the role of these interactions and how they result in the cannabinoid high experience continues to remain elusive.
